Slow adoption of GHTF guidelines by founding member nations offsets achievements
This article was originally published in SRA
Executive Summary
Progress the Global Harmonization Task Force has made in framing a universally acceptable medical devices regulatory framework is not having the desired impact because of the perception that the organisation’s founding member jurisdictions - the US, the European Union, Japan, Australia and Canada - are slow to adopt the GHTF approach into their own existing regulations1.